2011
$3M
from 5 investors over 5 rounds
NIRvana Sciences raised $3M on April 25, 2019
Investors: National Institute of Allergy and Infectious Diseases (NIAID)
NIRvana Sciences raised $1.1M on July 6, 2018
Investors: VentureSouth
NIRvana Sciences raised $1.4M on June 30, 2015
Investors: VentureSouth
NIRvana Sciences raised $1.4M on February 15, 2015
Investors: Charlotte Angel Fund
NIRvana Sciences raised undisclosed on January 1, 2012
Investors: NC IDEA & IDEA Fund Partners